Handelsavisen
prelaunch
Companies Healthcare BICO.ST
BI
BICO.ST Nasdaq Stockholm Advanced Medical Equipment & Technology

BICO Group AB

kr15,12
Open in Charts → Attach watcher ⌖
SEK
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-11,7 %
ROE
-2,6 %
Net margin
-18,4 %
Debt / equity
0,66
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

BICO Group AB is a provider of advanced medical equipment and technology, specializing in the development and commercialization of innovative solutions for the healthcare industry.

Business. BICO Group AB (BICO.ST) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on product sales. Headquartered in Sweden, the company is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
Generated · model-assisted
Sell-side consensus
HOLD3 analysts
1 buy2 hold0 sell
Avg 12m price target28,75

Analyst recommendations

3 analysts · consensus Hold
Buy1
Hold2
Sell0
12-month price target
28,75
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Hold
3 analysts · indicative
Ownership
not yet wired
Profitability
-2,6 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning BICO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to BICO.ST. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    BICO Group AB (BICO.ST) is a healthcare services and equipment company specializing in advanced medical equipment and technology. The firm operates within the Advanced Medical Equipment & Technology industry, focusing on product sales. Headquartered in Sweden, the company is primarily listed on the Nasdaq Stockholm exchange. Specific details regarding operating segments and geographic revenue mix are not provided.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryAdvanced Medical Equipment & Technology
    AI synthesis
    GENERATED

    BICO Group AB has a liquidity position that is currently medium, with a current ratio of 2.86, indicating the company can cover its short-term liabilities with its short-term assets. However, the company's free cash flow is negative at -50.2 million SEK, and operating cash flow is also negative at -68.2 million SEK, suggesting cash generation is a challenge. The company holds 687.6 million SEK in cash and equivalents, but this is offset by long-term debt of 1.957 billion SEK, resulting in a debt-to-equity ratio of 0.66.

    Profitability metrics for BICO Group AB are weak, with a return on equity of -2.64% and a return on assets of -1.37%. These figures are below the industry median for the Advanced Medical Equipment & Technology sector, indicating underperformance in generating returns for shareholders and asset utilization. The company reported a net loss of 77.8 million SEK and an operating loss of 49.6 million SEK, further highlighting the challenges in achieving profitability.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the provided data. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment-specific revenue data limits the ability to assess the performance of different product lines or geographic regions.

    Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a decline in revenue, with no clear indication of improvement in the next fiscal year. The negative operating and net income, combined with the lack of positive cash flow, suggests the company is not currently in a position to sustain growth without external financing or operational improvements.

    Risk factors for BICO Group AB include liquidity constraints and the potential for dilution, although the latter is currently assessed as low. The company's net cash position is negative after accounting for total debt, which could limit its ability to invest in growth opportunities or weather economic downturns. The risk assessment also highlights the need for the company to improve its cash flow generation and reduce debt levels to enhance financial stability.

    Recent events and disclosures indicate that the company is under pressure to improve its financial performance. Analysts have provided a mean price target of 28.75 SEK, with a median of 27.50 SEK, suggesting a cautious outlook. The mean recommendation of 2.67 (on a scale from 1 to 5) indicates a mixed sentiment, with no strong buy ratings and only one buy rating among the analysts surveyed.

    Key takeaways
    • BICO Group AB is currently unprofitable, with a net loss of 77.8 million SEK and an operating loss of 49.6 million SEK.
    • The company's liquidity position is medium, with a current ratio of 2.86, but it faces challenges in generating positive cash flow.
    • Return on equity and return on assets are negative, indicating poor performance in generating returns for shareholders and utilizing assets effectively.
    • The company's revenue is concentrated in a single segment, increasing exposure to regional and regulatory risks.
    • Analysts have a mixed outlook, with a mean price target of 28.75 SEK and a mean recommendation of 2.67.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 4

    Analysts project 114.9% upside to a mean price target of 28.75 SEK, significantly above the current market price of 13.38 SEK.

    Return on equity of -2.64% exceeds the cohort median of -4.71%, indicating relatively better capital efficiency among peers.

    Cash conversion ratio of 0.88 surpasses the cohort median of 0.79, suggesting superior operational cash generation relative to peers.

    Revenue demonstrated a 4.5% compound annual growth rate over the four-year period from 2022 to 2026.

    BEAR CASE · 2

    Debt-to-equity ratio of 0.66 places the company in the bottom quartile of its cohort, reflecting high leverage risk.

    Revenue declined 13.3% year-over-year to 1.50 billion SEK in FY2026, marking a contraction in top-line growth.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-30
    Q1 2026 · Quarter highlights

    Revenue kr 329.9M, −15,1% YoY; Operating income −43,5% YoY.

    Revenuekr 329.9M−15,1 % YoY
    Operating income-kr 113.5M−43,5 % YoY
    Net income-kr 131.4M+43,8 % YoY
    Free cash flow-kr 65.3M+62,9 % YoY
    EPS
    Operating cash flowkr 47.3M−38,2 % YoY
    Financials
    Income statement
    Revenuekr 329.9M
    Gross profitkr 99.3M
    Operating income-kr 113.5M
    Net income-kr 131.4M
    Margins
    Gross margin30.1%
    Operating margin-34.4%
    Net margin-39.8%
    FCF margin-19.8%
    Balance sheet
    Total assetskr 2.97B
    Total liabilitieskr 1.36B
    Total equitykr 1.61B
    Cash & equivalentskr 744.3M
    Long-term debtkr 690.6M
    Cash flow
    Operating cash flowkr 47.3M
    CapEx-kr 5.0M
    Free cash flow-kr 65.3M
    SBC
    P&L flow · revenue → net income
    Revenue kr 329.9MOperating costs kr 443.4MTax kr 17.9MNet income kr 131.4M
    Highlights
    • Revenue kr 329.9M, −15,1% YoY
    • Operating income −43,5% YoY
    • Net income +43,8% YoY
    • Free cash flow +62,9% YoY
    • Net margin -39.8%

    Valuation TTM

    Market price
    kr15,12
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    kr2.95B
    Net cash
    -kr1.27B
    Current ratio
    2.9
    Debt / equity
    0.7
    ROA
    -1.4%
    ROE
    -2.6%
    Cash conversion
    88.0%
    CapEx / revenue
    -9.1%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    -1,64
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-16 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate-1,64
    Revenueno estimateno estimate1,6B SEK
    Operating incomeno estimateno estimate-134,7M SEK
    Full-year consensus mean (period as reported by source) · consensus in SEK. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy0
    Buy1
    Hold2
    Sell0
    Strong sell0
    12-month price targetkr28,75 · Median kr27,50
    Low kr21,00High kr39,00
    Operating income · consensus-134,7M SEK
    EPS surprise
    −838,9 %
    reported vs consensus · miss
    Revenue surprise
    −5,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Lowkr21,00
    Meankr28,75
    Mediankr27,50
    Highkr39,00
    Spotkr15,12
    +90.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-11,7 %Above median
    Net Margin-18,4 %Below median
    ROE-2,6 %Below median
    Capex / Rev-9,1 %Below median
    D/E0,66Bottom quartile
    Cash Conv0,88Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Capex To Revenue
      capital_expenditure / revenue
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    Source documents
    • BICO Group AB Market data — financials · 2026-05-27
    • BICO Group AB Market data — analyst estimates · 2026-05-27
    • BICO Group AB Market data — ESG · 2026-05-27

    Ownership & reference

    Leadership

    • Maria ForssPresident, Chief Executive Officer

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    BICO.STCanonical
    Nasdaq Stockholm · SEK

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-04-30 05:09 UTCEARNINGSQuarterly results — Q1 2026 Revenue SEK 329.9M · Net SEK -131.4M
    2026-02-18 09:03 UTCEARNINGSQuarterly results — Q4 2025 Revenue SEK 451.3M · Net SEK -59.2M
    2026-02-18 09:03 UTCEARNINGSAnnual results — FY 2026 Revenue SEK 1.50B · Net SEK -1.09B
    2025-11-04 06:04 UTCEARNINGSQuarterly results — Q3 2025 Revenue SEK 386.9M · Net SEK -611.6M
    2025-08-19 06:00 UTCEARNINGSQuarterly results — Q2 2025 Revenue SEK 324.2M · Net SEK -184.2M
    2025-04-29 06:00 UTCEARNINGSQuarterly results — Q1 2025 Revenue SEK 388.6M · Net SEK -233.9M
    2025-02-19 06:00 UTCEARNINGSQuarterly results — Q4 2024 Revenue SEK 515.1M · Net SEK 346.8M
    2025-02-19 06:00 UTCEARNINGSAnnual results — FY 2025 Revenue SEK 1.73B · Net SEK -5.3M
    2024-11-26 06:00 UTCEARNINGSQuarterly results — Q3 2024 Revenue SEK 369.1M · Net SEK -246.1M
    2024-08-20 06:00 UTCEARNINGSQuarterly results — Q2 2024 Revenue SEK 423.3M · Net SEK -77.8M
    2024-02-20 06:03 UTCEARNINGSAnnual results — FY 2024 Revenue SEK 2.01B · Net SEK -1.17B
    2023-02-22 08:55 UTCEARNINGSAnnual results — FY 2023 Revenue SEK 2.12B · Net SEK -832.9M
    2022-02-23 08:09 UTCEARNINGSAnnual results — FY 2022 Revenue SEK 1.26B · Net SEK -227.6M
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage